Drucker Wealth 3.0’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
4,763
-249
-5% -$37.3K 0.12% 140
2026
Q1
$766K Buy
5,012
+35
+0.7% +$5.37K 0.13% 126
2025
Q4
$686K Sell
4,977
-29
-0.6% -$3.8K 0.12% 130
2025
Q3
$642K Sell
5,006
-593
-11% -$72.4K 0.11% 143
2025
Q2
$688K Sell
5,599
-1,355
-19% -$153K 0.13% 124
2025
Q1
$775K Sell
6,954
-1,471
-17% -$157K 0.17% 85
2024
Q4
$820K Sell
8,425
-578
-6% -$61.6K 0.19% 89
2024
Q3
$1.04M Buy
9,003
+193
+2% +$21.9K 0.25% 80
2024
Q2
$938K Buy
+8,810
New +$884K 0.25% 81

Other funds holding NVS

Drucker Wealth 3.0's NVS Position: Q2 2026 in Review

Drucker Wealth 3.0 reduced its Novartis (NVS) stake by 5% in Q2 2026, selling an estimated $37.3K and leaving 4,763 shares worth $746K. The position accounts for 0.12% of the portfolio, ranked #140.

Drucker Wealth 3.0 first reported a position in NVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.04M in Q3 2024. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Drucker Wealth 3.0 held 4,763 shares of Novartis worth $746K as of Q2 2026.
  • Drucker Wealth 3.0 sold 249 Novartis shares in Q2 2026, an estimated $37.3K.
  • Novartis made up 0.12% of Drucker Wealth 3.0's portfolio in Q2 2026, its #140 holding.
  • Drucker Wealth 3.0 first reported a position in Novartis in Q2 2024 and has held it in 9 quarters since.
  • Drucker Wealth 3.0's Novartis position peaked at $1.04M in Q3 2024.
  • 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Drucker Wealth 3.0's 13F filing for Q2 2026, filed 13 Jul 2026.